Prot #R668-AD-1225: An Open-Label Study of Dupilumab in Patients with Atopic Dermatitis Who Participated in Previous Dupilumab Clinical Trials

Project: Research project

StatusActive
Effective start/end date5/5/145/5/20

Funding

  • Parexel (Prot #R668-AD-1225)
  • Regeneron Pharmaceuticals, Inc. (Prot #R668-AD-1225)